New Delhi: A day ahead of the scheduled dry run for vaccination in all the states, a government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India (SII).
The panel will now forward its recommendation for final approval to the regulator Drugs Controller General of India (DCGI), NDTV reported quoting sources.
The expert panel recommending the affordable Oxford vaccine to the drugs regulator is a big development for India in the fight against the pandemic on the first day of the New Year, as the country has the second-biggest number of COVID-19 infections after the US. The government plans to vaccinate 30 crore people in the country in six to eight months.
The SII is making the vaccine Covishield developed by Oxford University and pharma major AstraZeneca, while Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for its Covaxin.
The two groups had made presentations before the panel on Wednesday. Pfizer had sought more time to present their data.
The Centre is looking to start giving vaccine shots from this month, once the vaccine is cleared for a final time by the DCGI.
Also Read: Oxford Vaccine Will Protect 95 Per Cent: AstraZeneca CEO
Berhampur: Taking a dig at Bharatiya Janata Party (BJP) for claiming to form government in…
Bhubaneswar: With twin polls less than a week away, the BJP is all set to…
New Delhi: Indian businesswoman and director of the MEIL Group Sudha Reddy graced the red…
Bhubaneswar: With thunderstorm activity accompanied by rain and gusty wind continuing in Odisha, the day…
Bhubaneswar: Biju Janata Dal (BJD) on Tuesday moved Odisha's Chief Electoral Officer (CEO) alleging that…
Bhubaneswar: In a surprise move, BJD nominee for Pipili Assembly seat Rudra Maharathy’s wife Jagruti…
Bhubaneswar: The BJP on Tuesday released a revised list of its 40 star campaigners for…
It’s official now! Odisha FC will represent India in the inaugural edition of the AFC…